Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasm, Residual × Folfox protocol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 118 Colonic Neoplasms 52 Rectal Neoplasms 46 Carcinoma, Hepatocellular 26 Neoplasm Metastasis 22 Stomach Neoplasms 20 Neoplasms 10 Pancreatic Neoplasms 9 Cholangiocarcinoma 8 Adenocarcinoma Of Esophagus 7 Liver Neoplasms 6 Esophageal Neoplasms 6 Biliary Tract Neoplasms 5 Recurrence 4 Gastrointestinal Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Esophageal Squamous Cell Carcinoma 3 Digestive System Neoplasms 3 Breast Neoplasms 3 Adenocarcinoma 3 Ovarian Neoplasms 2 Neurotoxicity Syndromes 2 Neoplastic Cells, Circulating 2 Gastrointestinal Diseases 2 Gallbladder Neoplasms 2 Cirrhosis, Familial, with Pulmonary Hypertension 2 Unresectable Metastatic Colorectal Cancer 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumors 1 Prostatic Neoplasms 1

Interventions

Cyclophosphamide 21 blinatumomab 16 Cytarabine 14 fludarabine 13 Azacitidine 12 venetoclax 10 fludarabine phosphate 9 Blood Specimen Collection 8 Rituximab 7 Methotrexate 7 Dexamethasone 7 Daunorubicin 7 Lenalidomide 6 Vincristine 5 Mercaptopurine 5 daratumumab 4 Whole-Body Irradiation 4 Melphalan 4 Idarubicin 4 Etoposide 4 obinutuzumab 3 Liquid Biopsy 3 Imatinib Mesylate 3 Granulocyte Colony-Stimulating Factor 3 Doxorubicin 3 Cladribine 3 Chemotherapy, Adjuvant 3 Busulfan 3 Asparaginase 3 trastuzumab deruxtecan 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05534087 2024-11-29

CLAUDIA

Seoul National University Hospital

Phase 3 Recruiting

Gastrointestinal

Colonic Neoplasms, Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon ⚡